Speaker and moderators

  • Agosta Federica, Neuroimaging Research Unit, INSPE, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University
  • Alberti Simon, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
  • Appel Stanley, Department of Neurology, Methodist Hospital Research Institute, Houston, Tx, USA
  • Bemporad Francesco, Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence
  • Bendotti Caterina, Neuroscience Department, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan
  • Biferi Maria Grazia, Center of Research in Myology, INSERM, France
  • Bonanno Giambattista, Pharmacy Department, University of Genova, Genova
  • Bonanno Silvia, I.R.C.C.S. Neurological Institute C. Besta, Neuromuscular Diseases and Neuroimmunology, Milan, (Italy), University of Milano-Bicocca, Thomas Jefferson University, Weinberg ALS Center, Philadelphia, USA
  • Bonetto Valentina, Department of Biochemistry and Molecular Pharmacology, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan
  • Bonifacino Tiziana, Department of Pharmacy, Unit of Pharmacology and Toxicology, University of Genoa
  • Bozzoni Irene, Department of Biology and Biotechnology “Charles Darwin”, University La Sapienza, Roma
  • Bucci Marco, Major of the District of Genoa
  • Buratti Emanuele, International Centre for Genetic Engineering and Biotechnology, Trieste
  • Caponnetto Claudia, Department of Neurosciences, Ophthalmology, Rehabilitation, Genetics and Maternal-Infant Sciences, Ospedale Policlinico San Martino, Genova
  • Carra Serena, Department of Biomedical, Metabolic and Neuroscience Sciences, University of Modena and Reggio Emilia
  • Castelnovo Veronica, Neuroimaging Research Unit, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan
  • Chiò Adriano, Centro Regionale Esperto per la SLA (CRESLA), University of Turin
  • Cicardi Maria Elena, Department of pharmacological and biomolecular science, University of Milan
  • Cocozza Germana, Department of Physiology and Pharmacology, Sapienza University, Rome, Center for Life Nanoscience – Istituto Italiano di Tecnologia@Sapienza, Rome, Italy
  • Corti Stefania, Department of Medical-Surgical Physiopathology and Transplantation, University of Milan
  • Crippa Valeria, Department of Pharmacological and Biomedical Sciences, University of Milan
  • Edbauer Dieter, Ludwig-Maximilians University of Munchen, Germany
  • Emmenegger Marc, Institute of Neuropathology, University Hospital, Zurigo, Swizerland
  • Feiguin Fabian, International Centre for Genetic Engineering and Biotechnology, Trieste
  • Ferraiuolo Laura, Department of Neuroscience, University of Sheffield, UK
  • Fontana Alberto, AriSLA Foundation President
  • Fumagalli Marta, Department of Pharmacological and Biomolecular Sciences, University of Milan
  • Garofalo Stefano, Department of Physiology and Pharmacology, Sapienza University of Rome
  • Giunchiglia Enrico, Pro-Rector of the University of Genoa
  • Glass Jonathan D., Department of Neurology & Pathology, Emory University, Atlanta
  • Greensmith Linda, University College London, Institute of Neurology, UK
  • Logroscino Giancarlo, Department of Basic Medical Sciences, Neurosciences and Sense Organs, University Aldo Moro of Bari, Italy
  • Lunetta Christian, NEMO Clinical Center, Fondazione Serena Onlus, Milan
  • Mancardi Gianluigi, President of Italian Society of Neurology
  • Marcuzzo Stefania, Neurology IV –Neuroimmunology and Neuromuscular Diseases Unit, Fondazione Istituto Neurologico “Carlo Besta”, Milan
  • Marrone Lara, DFG-Center for Regenerative Therapies, Technische Universität Dresden, Fetscherstr, Germany
  • Markus Nora, SITraN, University of Sheffield, Sheffield, UK
  • Mauro Massimo, AISLA President
  • Melazzini Mario, Direttore Scientifico Centrale ICS Maugeri SB IRCCS
  • McCampbell Alexander, Biogen, Cambridge, MA
  • Milanese Marco, Pharmacy Department, University of Genova, Genova
  • Moglia Cristina, CRESLA, Department of Neuroscience, University of Turin
  • Musarò Antonio, University La Sapienza, Rome
  • Nardo Giovanni, Neuroscience Department, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan
  • Paganetti Paolo, Laboratory for Biomedical Neurosciences, Neurocenter of Southern Switzerland
  • Pasinelli Piera, Frances & Joseph Weinberg, Jefferson Weinberg ALS Center, Vickie & Jack Farber Institute for Neuroscience, Department of Neuroscience, Thomas Jefferson University, Philadelphia, The Robert Packard Center for ALS Research, Baltimora, USA
  • Petrozziello Tiziana, Department of Neuroscience, Reproductive and Odontostomatological Sciences, University of Naples “Federico II”
  • Poletti Angelo, Department of Pharmacological and Biomedical Sciences, University of Milan
  • Ratti Antonia, IRCCS Istituto Auxologico Italiano, Department of medical-surgical and transplants physiopathology, “Dino Ferrari” Center, University of Milan
  • Rosa Alessandro, Department of Biology and Biotechnology “Charles Darwin”, University La Sapienza, Rome
  • Sabatelli Mario, NEMO Clinical Center, University Cattolica del Sacro Cuore, Rome
  • Shaw Pamela, Department of Neuroscience, University of Sheffield, UK
  • Silani Vincenzo, IRCCS Istituto Auxologico Italiano, Department of medical-surgical and transplants physiopathology, “Dino Ferrari” Center, University of Milan
  • Sterneckert Jared, Center for Regenerative Therapies Dresda, Germany
  • Trotti Davide, Jefferson Weinberg ALS Center, Vickie and Jack Farber Institute for Neurosciences, Department of Neuroscience, Sidney Kimmel Medical College, Thomas Jefferson University Hospitals, Philadelphia, PA, USA
  • Van Den Bosch Ludo, KU Leuven, University of Leuven, Department of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), VIB, Center for Brain & Disease Research, Laboratory of Neurobiology, Leuven, Belgium
  • Viale Sonia, Councilor for Health of Liguria region
  • Zaglia Tania, Department of Cardiologic, Thoracic and Vascular Sciences, University of Padova